These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36332083)

  • 41. Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.
    Miyagawa-Hayashino A; Egawa H; Yoshizawa A; Ueda Y; Ichida T; Ueno Y; Uemoto S; Harada K; Nakanuma Y
    Hum Pathol; 2011 Sep; 42(9):1329-36. PubMed ID: 21334714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case Report: Simultaneously Developed Amyopathic Dermatomyositis and Autoimmune Sclerosing Cholangitis - a Coincidence or a Shared Immunopathogenesis?
    Ledenko T; Sorić Hosman I; Ćorić M; Gagro A
    Front Immunol; 2022; 13():825799. PubMed ID: 35281002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.
    Liberal R; Vergani D; Mieli-Vergani G
    Liver Transpl; 2016 Sep; 22(9):1275-83. PubMed ID: 27257963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression.
    Liberal R; Grant CR; Holder BS; Cardone J; Martinez-Llordella M; Ma Y; Heneghan MA; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2015 Sep; 62(3):863-75. PubMed ID: 25953611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.
    Steinmann S; Hartl J; Weidemann S; Füssel K; Kroll C; Sebode M; Lohse AW; Schramm C
    JHEP Rep; 2023 Dec; 5(12):100898. PubMed ID: 37954487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.
    Kerkar N; Chan A
    Clin Liver Dis; 2018 Nov; 22(4):689-702. PubMed ID: 30266157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-TNFα Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease.
    Nedelkopoulou N; Vadamalayan B; Vergani D; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):100-105. PubMed ID: 28953529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal homeostasis in autoimmune liver diseases.
    Liu Q; He W; Tang R; Ma X
    Chin Med J (Engl); 2022 Jul; 135(14):1642-1652. PubMed ID: 36193976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    Cha HJ; Hwang J; Lee LE; Park Y; Song JJ
    PLoS One; 2021; 16(1):e0244950. PubMed ID: 33411840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two decades of research on autoimmune liver disease in Turkey.
    Demir N; Ekin N; Torgutalp M; Wahlin S; Efe C
    Turk J Gastroenterol; 2020 Dec; 31(12):877-882. PubMed ID: 33626000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Causal effect of autoimmune liver diseases on cancer: Meta-analyses of cohort studies and Mendelian randomization study.
    Gu D; Zhang M; Wang Y; Bai Y; Wang X; Deng G
    Liver Int; 2022 Oct; 42(10):2216-2226. PubMed ID: 35775855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
    Ludz C; Stirnimann G; Semela D; Mertens J; Kremer AE; Filipowicz Sinnreich M; Sokollik C; Bernsmeier C; Bresson-Hadni S; McLin V; Rock N; Braegger C; Posovszky C; Müller P; Cremer M; De Gottardi A; Galante A; Furlano R; Righini-Grunder F; Becker B; Böhm S; Heyland K; Nydegger A; Limoni C; Vergani D; Mieli-Vergani G; Di Bartolomeo C; Cerny A; Terziroli Beretta-Piccoli B
    Swiss Med Wkly; 2023 Aug; 153():40102. PubMed ID: 37769636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex-related factors in autoimmune liver diseases.
    Schwinge D; Schramm C
    Semin Immunopathol; 2019 Mar; 41(2):165-175. PubMed ID: 30276446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
    Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgG4-related autoimmune liver disease.
    Capurso G; Pedica F; Palumbo D; Della-Torre E
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):23-49. PubMed ID: 33267565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases.
    McNair AN; Moloney M; Portmann BC; Williams R; McFarlane IG
    Am J Gastroenterol; 1998 May; 93(5):777-84. PubMed ID: 9625127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
    Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
    Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between autoimmune liver disease and autoimmune thyroid disease: a cross-sectional study.
    Zeng Q; Zhao L; Wang C; Gao M; Han X; Chen C; Tu C; Han P; Li J
    Scand J Gastroenterol; 2020 Feb; 55(2):216-221. PubMed ID: 32083943
    [No Abstract]   [Full Text] [Related]  

  • 59. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.
    Lewin M; Vilgrain V; Ozenne V; Lemoine M; Wendum D; Paradis V; Ziol M; Arrivé L; Beaugrand M; Poupon R; Valla D; Chazouillères O; Corpechot C
    Hepatology; 2009 Aug; 50(2):528-37. PubMed ID: 19575454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in liver transplantation for autoimmune liver diseases: a Canadian study.
    Murillo Perez CF; Ivanics T; Claasen MPAW; Yoon P; Wallace D; Selzner N; Hirschfield GM; Hansen BE; Sapisochin G
    Can J Surg; 2022; 65(5):E665-E674. PubMed ID: 36223935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.